Skip to main content

Karthik Devarajan CMILT

GDP Compliance Manager & RP, Health Hub, Reckitt Benckiser Group plc

Karthik's Story...

Joining CILT UK marked a defining step in my professional journey. Working at the intersection of quality, logistics, and regulatory compliance within the pharmaceutical supply chain, I have consistently focused on ensuring safe, efficient, and reliable operations that ultimately protect patient outcomes.

View full story:

View here

Joining CILT UK marked a defining step in my professional journey. Working at the intersection of quality, logistics, and regulatory compliance within the pharmaceutical supply chain, I have consistently focused on ensuring safe, efficient, and reliable operations that ultimately protect patient outcomes.

Early in my career, I recognised that operational experience alone was not enough to address the growing complexity of global pharmaceutical logistics. I was motivated to strengthen my professional foundation and align my work with recognised industry standards. Becoming a member of CILT provided that structure, offering both a global perspective and a disciplined framework for continuous improvement.

Through my role as a Quality Manager and Responsible Person, I have led initiatives to enhance GDP compliance, strengthen supply chain integrity, and embed quality-driven decision-making across pharmaceutical distribution operations. These experiences reinforced the importance of professional recognition not only as a milestone, but as a commitment to excellence, patient safety, and accountability.

Achieving Chartered status has strengthened my credibility and enabled me to influence best practices more effectively within my organisation and the broader pharmaceutical and logistics industry. It has also deepened my engagement with the professional community, supporting knowledge-sharing and ongoing development.

For me, CILT represents more than a professional body it is a platform that reinforces standards, drives innovation, and empowers individuals to contribute meaningfully to the future of pharmaceutical supply chains and global logistics.